Trinity Biotech reported $34.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
EDAP TMS EUR 31.4M 2.71M Sep/2025
J&J USD 57.72B 3.59B Mar/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Siemens EUR 49.52B 168M Mar/2026
Surmodics USD 19.44M 1.1M Jun/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Tosoh JPY 354.52B 14.24B Mar/2026
Trinity Biotech USD 34.49M 2.97M Sep/2025
Veracyte USD 56.11M 3.82M Mar/2026